Parvathy Venugopal
Parvathy Venugopal
Centre for Cancer Biology
Verified email at
Cited by
Cited by
Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia
U Nekanti, S Dastidar, P Venugopal, S Totey, M Ta
International journal of biological sciences 6 (5), 499, 2010
Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications
U Nekanti, L Mohanty, P Venugopal, S Balasubramanian, S Totey, M Ta
Stem cell research 5 (3), 244-254, 2010
Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study
P Swamynathan, P Venugopal, S Kannan, C Thej, U Kolkundar, ...
Stem cell research & therapy 5, 1-17, 2014
Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow
S Balasubramanian, C Thej, P Venugopal, N Priya, Z Zakaria, ...
Cell biology international 37 (5), 507-515, 2013
Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells
S Balasubramanian, P Venugopal, S Sundarraj, Z Zakaria, AS Majumdar, ...
Cytotherapy 14 (1), 26-33, 2012
Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions
P Venugopal, S Balasubramanian, AS Majumdar, M Ta
Stem Cells and Cloning: Advances and Applications, 39-50, 2011
Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes
CE Chong, P Venugopal, PH Stokes, YK Lee, PJ Brautigan, DTO Yeung, ...
Leukemia 32 (1), 194-202, 2018
Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy
CN Hahn, P Venugopal, HS Scott, DK Hiwase
Immunological reviews 263 (1), 257-278, 2015
Revealing Missing Human Protein Isoforms Based on Ab Initio Prediction, RNA-seq and Proteomics
Z Hu, HS Scott, G Qin, G Zheng, X Chu, L Xie, DL Adelson, BE Oftedal, ...
Scientific reports 5 (1), 10940, 2015
GATA2 deficiency syndrome: a decade of discovery
CC Homan, P Venugopal, P Arts, NH Shahrin, S Feurstein, L Rawlings, ...
Human Mutation 42 (11), 1399-1421, 2021
Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient
P Venugopal, S Moore, DM Lawrence, AJ George, RD Hannan, SCE Bray, ...
Haematologica 102 (12), e506, 2017
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
C Saygin, G Roloff, CN Hahn, R Chhetri, S Gill, H Elmariah, C Talati, ...
Blood Advances 7 (4), 549-554, 2023
A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature
J Kazenwadel, P Venugopal, A Oszmiana, J Toubia, L Arriola-Martinez, ...
Nature 614 (7947), 343-348, 2023
Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia
CN Hahn, PJ Brautigan, CE Chong, A Janssan, P Venugopal, Y Lee, ...
Leukemia 29 (8), 1795-1797, 2015
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
CC Homan, MW Drazer, K Yu, DM Lawrence, J Feng, L Arriola-Martinez, ...
Blood Advances 7 (20), 6092-6107, 2023
Somatic mutational landscape of hereditary hematopoietic malignancies associated with germline variants in RUNX1, GATA2 and DDX41
AL Brown, C Homan, MW Drazer, K Yu, D Lawrence, J Feng, ...
Blood 140 (Supplement 1), 4030-4033, 2022
Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss
P Venugopal, L Gagliardi, C Forsyth, J Feng, K Phillips, M Babic, ...
BMC Medical Genetics 21, 1-5, 2020
Clinical implications of transient myeloproliferative disorder in a neonate without Down syndrome features
V Carruthers, M Nicola, P Venugopal, CN Hahn, HS Scott, T Revesz
Journal of paediatrics and child health 53 (10), 1018-1020, 2017
An integrative genomic approach to examine mutations and biological pathways associated with hematological malignancy development in DDX41 mutated families
P Venugopal, JJC Cheah, L Eshraghi, NH Shahrin, C Homan, J Feng, ...
Blood 134, 2686, 2019
Australian Familial Haematological Cancer Study-findings from 15 years of aggregated clinical, genomic and transcriptomic data
CN Hahn, M Babic, PJ Brautigan, P Venugopal, K Phillips, J Dobbins, ...
Blood 134, 1439, 2019
The system can't perform the operation now. Try again later.
Articles 1–20